Journal
NEUROMUSCULAR DISORDERS
Volume 21, Issue 5, Pages 353-355Publisher
PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.nmd.2011.02.005
Keywords
SMARD1; IGHMBP2; Neuromuscular degeneration mouse; Motor neuron disease
Categories
Funding
- NIH, National Institutes of Health
Ask authors/readers for more resources
Spinal muscular atrophy with respiratory distress (SMARD1) presents within the first 13 months of age with low birth weight, progressive length dependent motor neuropathy, and respiratory failure from diaphragmatic paralysis. SMARD1 is caused by mutations in IGHMBP2, encoding the immunoglobulin p.-binding protein 2. Because of the severity of the disorder, many infantile-onset SMARD1 patients do not live past the first decade of life. This report documents the clinical course of a 20-year-old man diagnosed with SMARD1. Published by Elsevier B.V.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available